Lymphoid leukosis (LL) is virus-induced, lymphoblastic malignancy of chickens that can be congenitally transmitted. Mortality from LL is generally low. Effects of LL virus (LLV) on production and mortality were investigated in approximately 2000 Leghorn pullets in each of two consecutive years. The pullets were from nine strains developed in Ottawa, of which three were unselected control strains and six were strains under selection for up to 27 generations for high egg production and a complex of related commercially important traits. The overall frequency of birds shedding LL virus of gs antigen into eggs (LL-S) was significantly lower in the selected strains (3.9%) than in the control strains (18.5%), indicating that LLV may have negative effects on production and cause elimination of LL-S birds by selection. Such significant effects were indeed detected: the LL-S pullets produced to 497 days of age in 1976 and 1977, respectively, 30 and 25 eggs less per hen-housed than the nonshedders. The LL-S birds matured sexually later, produced smaller eggs at a lower rate, and their eggs had a lower specific gravity, indicating thinner shells. Mortality from all causes to 497 days was significantly higher in LL-S birds (+14.8%) in 1976. In 1977 the increase (+5.5%) did not reach statistical significance. In both years the mortality from LL itself remained very low. In another study, eggs from one of the control strains were incubated and hatched from the dams were 291 and 483 days old. The eggs from LL-S dams had 2.4% lower fertility and 12.4% lower hatchability. The effects on hatchability were more pronounced in the older dams. Since the lower production of LL-S birds results in a lower frequency of such birds in strains selected for high egg production, it is suggested that a part of the difference between the performance of the selected and control strains (delta S) is due to reduction in the frequency of LL-S birds (delta L) rather than due to true genetic gain. In this study, the size of delta L relative to delta S was estimated at 4 to 14% for egg production and 3 to 7% for egg weight. The negative effects of LLV infection on egg production, mortality, hatchability, and genetic gains show the desirability of producing chickens free of LLV infection.
Six strains under long-term selection for egg production and other economically-important traits were crossed in a full diallel, and tested with two commercial stocks and two control strains at two stocking rates (1 bird per 20.3-cm cage and 3 birds per 30.5-cm cage) and two diets (with and without an oyster shell supplement). The mean of the 30 strain crosses exceeded the mean of the six selected strains for egg production and egg quality traits, sexual maturity and viability, which in turn exceeded the performance of both of the control strains. The performance of several of the 30 strain crosses was similar to the commercial stocks. The only significant genotype X environment interaction was for Haugh units at 450 d. Performance at the lower stocking rate was generally superior to that at the higher stocking rate. General combining ability was important for the complete array of traits measured. Specific combining ability was important for the majority of traits. Heterosis was important for all traits except specific gravity, Haugh units, blood spots and laying house viability to 272 or 496 d at the higher stocking rate. The magnitude of heterotic effects was generally greater at the higher stocking rate. Reciprocal effects were important for egg production traits, sexual maturity, egg quality traits and viability. The dietary oyster shell supplement resulted in an improvement in shell quality as measured by specific gravity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.